People · Operator
Named in public records as an officer, director or promoter · active 2013–2016 · Other Technology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| N12 Technologies, Inc. | — | Other Technology | Series B | $30.0M | $703.0M | 2013 |
| Resilience Therapeutics, Inc. | — | Pharmaceuticals | Seed | $8.4M | $19.0M | 2015 |
Jeffrey R. Sabados at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jeffrey R. Sabados on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Bradley Berkson | 1 | 3 |
| Trip Flavin | 1 | 2 |
| Trip R. Flavin | 1 | 1 |
| Brian R. Wardle | 1 | 1 |
| Jason E Fuller | 1 | 1 |
| William M Cowan | 1 | 1 |
| Jeffrey Sinclair | 1 | 1 |
| Rob Schiller | 1 | 1 |
| Retsina M Meyer | 1 | 1 |
| Jeff R. Sinclair | 1 | 1 |
| Restina M Meyer | 1 | 1 |
| Bradley R. Berkson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.